Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03736044Completed
Open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Primary endpoint: Proportion of subjects who flare-up after cessation of anti-TNF therapy at 24 months. Started Nov 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03736044.